Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil | [4] Methylprednisolone Methylprednisolone,Mycophenolate mofetil, Mycophenolic acid, Prednisone | [11] D00407
D00407
(Name: Methylprednisolone),D00473 , D00751 (Name: Methylprednisolone sodium succinate), D00752 , D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate), D05094 , D05095 , D05096 | [3] IMPDH1 IMPDH1,IMPDH2, NR3C1 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | [1] 49 49 |
| 2 | Administration of methylprednisolone, paracetamol and dexchlorpheniramine | [3] Acetaminophen Acetaminophen,Dexchlorpheniramine, Methylprednisolone | [8] D00217
D00217
,D00407 (Name: Methylprednisolone), D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate), D07803 | [4] HRH1 HRH1,NR3C1, PTGS1, PTGS2 💬 | [26] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 49 49 |
| 3 | Administration of rituximab and methylprednisolone | [2] Methylprednisolone Methylprednisolone,Rituximab | [7] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D02994 , D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [2] MS4A1 MS4A1,NR3C1 💬 | [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 51 51 |
| 4 | Corticosteroid treatment (Methylprednisolone or prednisolone) | [2] Methylprednisolone Methylprednisolone,Prednisolone | [14] D00407
D00407
(Name: Methylprednisolone),D00472 , D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D00980 , D00981 , D00982 , D01239 , D01998 , D02156 , D03301 , D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 64 64 |
| 5 | Cyclophosphamide, Azathioprine,prednisone,methylprednisolone | [4] Azathioprine Azathioprine,Cyclophosphamide, Methylprednisolone, Prednisone | [11] D00238
D00238
,D00287 , D00407 (Name: Methylprednisolone), D00473 , D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D03033 , D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate), D07760 | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 42 42, 43, 45 |
| 6 | Infliximab, methylprednisolone, methotrexate | [3] Infliximab Infliximab,Methotrexate, Methylprednisolone | [9] D00142
D00142
,D00407 (Name: Methylprednisolone), D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D02115 , D02598 , D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [4] DHFR DHFR,DHFR2, NR3C1, TNF 💬 | [72] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
| 7 | Interferon-beta-1a (Avonex) plus methylprednisolone | [3] Human interferon beta Human interferon beta,Interferon beta-1a, Methylprednisolone | [7] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D04554 , D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [3] IFNAR1 IFNAR1,IFNAR2, NR3C1 💬 | [19] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 |
| 8 | Intravenous (i.v.) methylprednisolone 1000 mg, total 9 | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 222 222 |
| 9 | Intravenous Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 13 13, 145 |
| 10 | IV methylprednisolone | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
| 11 | IV methylprednisolone (steroids) | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
| 12 | Megadose oral methylprednisolone | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
| 13 | Methotrexate + Methylprednisolone | [2] Methotrexate Methotrexate,Methylprednisolone | [8] D00142
D00142
,D00407 (Name: Methylprednisolone), D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D02115 , D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [3] DHFR DHFR,DHFR2, NR3C1 💬 | [6] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬 | [1] 46 46 |
| 14 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
| 15 | Methylprednisolone (drug) | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
| 16 | Methylprednisolone (MP) | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 60 60, 285 |
| 17 | Methylprednisolone (MP) or prednisone (pred) | [2] Methylprednisolone Methylprednisolone,Prednisone | [7] D00407
D00407
(Name: Methylprednisolone),D00473 , D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 |
| 18 | Methylprednisolone (or other glucocorticoid) | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 43 43 |
| 19 | Methylprednisolone (Solu-Medrol) | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 14 14 |
| 20 | Methylprednisolone 1250 mg/24h x3 days | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
| 21 | METHYLPREDNISOLONE ACETATE | [2] Acetate Acetate,Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 46 46, 51 |
| 22 | Methylprednisolone and azathioprine | [2] Azathioprine Azathioprine,Methylprednisolone | [8] D00238
D00238
,D00407 (Name: Methylprednisolone), D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D03033 , D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 93 93, 95 |
| 23 | Methylprednisolone and Mycophenolate mofetil | [3] Methylprednisolone Methylprednisolone,Mycophenolate mofetil, Mycophenolic acid | [10] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00752 , D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate), D05094 , D05095 , D05096 | [3] IMPDH1 IMPDH1,IMPDH2, NR3C1 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | [2] 93 93, 95 |
| 24 | Methylprednisolone bolus IV 15 mg/kg/d for 3 days. | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 84 84 |
| 25 | Methylprednisolone hemisuccinate | [2] Methylprednisolone Methylprednisolone,Methylprednisolone hemisuccinate | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
| 26 | Methylprednisolone IV | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
| 27 | METHYLPREDNISOLONE MYLAN Générique | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 |
| 28 | Methylprednisolone or budesonide | [2] Budesonide Budesonide,Methylprednisolone | [7] D00246
D00246
,D00407 (Name: Methylprednisolone), D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 96 96 |
| 29 | Methylprednisolone or Prednisolone | [2] Methylprednisolone Methylprednisolone,Prednisolone | [14] D00407
D00407
(Name: Methylprednisolone),D00472 , D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D00980 , D00981 , D00982 , D01239 , D01998 , D02156 , D03301 , D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 65 65 |
| 30 | Methylprednisolone PO | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
| 31 | Methylprednisolone pulse | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 66 66, 220 |
| 32 | METHYLPREDNISOLONE SODIUM HEMISUCCINATE | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 13 13, 97 |
| 33 | METHYLPREDNISOLONE SODIUM SUCCINATE | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [6] 13 13, 46, 49, 50, 51, 211 |
| 34 | Methylprednisolone succinate | [2] Methylprednisolone Methylprednisolone,Methylprednisolone hemisuccinate | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
| 35 | Methylprednisolone(intravenously in the 1st-2nd-3rd month ) | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 |
| 36 | Methylprednisolone(intravenously in the 1st-3rd-5th month) | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 66 66 |
| 37 | Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone | [2] Mesalazine Mesalazine,Methylprednisolone | [7] D00377
D00377
,D00407 (Name: Methylprednisolone), D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
| 38 | Oral Methylprednisolone 625 mg/24h x3 days | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
| 39 | Other: Exposure to methylprednisolone during pregnancy | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
(Name: Methylprednisolone),D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
| 40 | Prednisone (and methylprednisolone) | [2] Methylprednisolone Methylprednisolone,Prednisone | [7] D00407
D00407
(Name: Methylprednisolone),D00473 , D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 43 43 |
| 41 | Prednisone, methylprednisolone,cyclophosphamides | [2] Methylprednisolone Methylprednisolone,Prednisone | [7] D00407
D00407
(Name: Methylprednisolone),D00473 , D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 42 42, 43, 45 |
| 42 | Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone) | [2] Methylprednisolone Methylprednisolone,Ursodeoxycholic acid | [7] D00407
D00407
(Name: Methylprednisolone),D00734 , D00751 (Name: Methylprednisolone sodium succinate), D00979 (Name: Methylprednisolone acetate), D05000 (Name: Methylprednisolone hemisuccinate), D05001 (Name: Methylprednisolone sodium phosphate), D05002 (Name: Methylprednisolone suleptanate) | [2] NR1H4 NR1H4,NR3C1 💬 | [2] Bile secretion Bile secretion, Neuroactive ligand-receptor interaction 💬 | [1] 93 93 |